ISDS Case Map
medicines
Commerce minister Anand Sharma said on Monday that a proposed free-trade agreement (FTA) with the European Union (EU) would not hurt the generic drugs industry. The minister also said India would attract the same amount of foreign direct investment as last year.
As part of its support to Uganda's implementation of the Economic Partnership Agreement between the European Union and East Africa, the EU is funding the drafting of Kampala's controversial Counterfeit Goods Bill, which has caused an outcry as it threatens access to life-saving generic medicines in this low income East African country.
With the looming threat of these supply lines being disrupted by TRIPS+ provisions that are likely to be demanded of the Indian Government by FTA negotiators from the European Union and Japan we request that the Indian Government stand firm on their position of refusing all TRIPS+ provision that maybe included in any final agreement.
Poor people in India and other developing countries may lose access to affordable generic drugs as part of free-trade negotiations between India and the European Union, a medical advocacy group said on Friday.
Far-reaching provisions on the patenting of medicine have been inserted into a controversial free trade agreement between the European Union and Colombia and Peru.
The eighth round of the FTA talks which took place in Mumbai last week have been strongly criticised in India for their secrecy and lack of consultation with the national parliament and state governments.
Whichever FTA is signed first -- Japan's or the EU's -- will put pressure on the other pair of negotiators to reach pragmatic compromises. The race for India is on.
The Peruvian Network for a Just Globalization says that both public opinion, as well as members of Congress, have to make sure that no conditions that restrict access to medicines for thousands of
Peruvians are included in the text of the EU-Peru trade agreement.
Amid fresh talks on the India-Japan free trade agreement (FTA), concerns are being expressed about certain measures that could hamper generic drugs and access to medicines.
The European Union on Friday said it would prefer to resolve two commercial disputes with India without engaging in a legal battle at the World Trade Organisation (WTO). The first dispute involves seizure of Indian generic drugs in transit at some EU-based ports, including Amsterdam, which were bound for certain third world countries, on the grounds of patents infringement.
